AdaptHealth Corp. (AHCO)

Import this data to Google Sheets with:

=jivedata("AHCO","financials")

Full statements spill as a table. For one cell: =jivedata("AHCO","Revenue") or =jivedata("AHCO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

AdaptHealth Corp.

AHCO • CIK 0001725255

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$3,200,177	$3,260,975	$3,244,857	$3,086,783
Gain (Loss) on Disposition of Business	—	—	$32,602	$6,646
Operating Income (Loss)	$-598,401	$263,732	$90,873	$-154,772
Interest Income (Expense), Nonoperating, Net	—	$-126,668	$-105,753	$-101,624
Gain (Loss) on Extinguishment of Debt	$0	$-2,273	$0	$-1,322
Fair Value Adjustment of Warrants	$-34,482	$-4,021	$0	$0
Other Nonoperating Income (Expense)	$-29,566	$-2,793	$-274	$-274
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-723,784	$136,019	$-15,154	$-257,992
Income Tax Expense (Benefit)	$-49,004	$41,239	$50,884	$-14,249
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-674,780	$94,780	$-66,038	$-223,379
Net Income (Loss) Attributable to Noncontrolling Interest	$4,115	$4,358	$4,756	$4,851
Net Income (Loss) Attributable to Parent	$-678,895	$90,422	$-70,794	$-228,230
Weighted Average Number of Shares Outstanding, Basic	134,156,000	133,756,000	135,146,000	136,199,000
Weighted Average Number of Shares Outstanding, Diluted	134,418,000	135,531,000	135,146,000	133,915,000
Cost of Goods and Services Sold	$2,720,613	$2,579,882	$2,635,658	$2,552,842
General and Administrative Expense	$190,091	$359,238	$382,293	$387,980
Goodwill, Impairment Loss	$830,787	$13,078	$127,995	$272,231
Costs and Expenses	$3,798,578	$2,997,243	$3,186,586	$3,248,201
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic	$0	$7,675	$0	$-629
Net Income (Loss) Available to Common Stockholders, Basic	$-678,895	$82,747	$-70,794	$-79,627
Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities	—	—	$0	$0
Net Income (Loss) Available to Common Stockholders, Diluted	$-713,377	$82,747	$-70,794	$-79,627
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants	262,000	0	0	0
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	0	251,000	0	0
Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends	0	1,524,000	0	0

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$77,132	$109,747	$106,136	$47,964
Accounts Receivable, after Allowance for Credit Loss, Current	$388,910	$408,019	$370,897	$390,389
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	$495,101	$474,556	$509,956	$656,368
Inventory, Net	$113,642	$139,842	$151,247	$105,480
Operating Lease, Right-of-Use Asset	$110,465	$105,999	$111,968	$127,204
Prepaid Expense and Other Assets, Current	$69,338	$45,432	$100,619	$90,219
Disposal Group, Including Discontinued Operation, Assets, Current	—	$52,748	$0	$168,098
Goodwill	$2,724,958	$2,675,166	$2,541,428	$2,370,431
Assets, Current	$649,022	$755,788	$728,899	$797,475
Intangible Assets, Net (Excluding Goodwill)	$130,160	$105,548	$85,121	$31,780
Deferred Income Tax Assets, Net	$345,854	$314,505	$267,786	$290,720
Other Assets, Noncurrent	$21,128	$17,584	$19,119	$22,090
Assets	$4,508,650	$4,486,947	$4,316,577	$4,340,869
Long-term Debt, Excluding Current Maturities	$2,094,614	$1,964,921	$1,715,983	$1,879,809
Operating Lease, Liability, Noncurrent	$85,529	$80,275	$85,470	$96,352
Finance Lease, Liability, Noncurrent	$22,746	$24,630	$32,604	$32,604
Other Liabilities, Noncurrent	$302,093	$272,016	$243,804	$243,805
Liabilities	$3,041,981	$2,908,829	$2,790,253	$2,954,613
Accounts Payable and Accrued Liabilities, Current	$391,994	$437,985	$553,700	$576,300
Long-term Debt, Current Maturities	$53,368	$16,250	$20,313	$8,125
Operating Lease, Liability, Current	$29,270	$29,945	$30,728	$36,030
Finance Lease, Liability, Current	$9,122	$14,315	$17,702	$19,337
Contract with Customer, Liability, Current	$38,570	$34,944	$59,843	$64,743
Other Liabilities, Current	$10,654	$26,505	$30,106	$4,117
Disposal Group, Including Discontinued Operation, Liabilities, Current	—	$7,043	$0	$560
Liabilities, Current	$536,999	$566,987	$712,392	$709,212
Common Stock, Value, Issued	$13	$13	$13	$14
Preferred Stock, Value, Issued	$1	$1	$1	$1
Treasury Stock, Common, Value	$43,267	$25,548	$25,548	$25,548
Additional Paid in Capital	$2,149,951	$2,156,604	$2,176,990	$2,186,940
Retained Earnings (Accumulated Deficit)	$-652,600	$-562,178	$-632,972	$-782,941
Accumulated Other Comprehensive Income (Loss), Net of Tax	$4,356	$2,253	$78	$0
Stockholders' Equity Attributable to Parent	$1,458,454	$1,571,145	$1,518,562	$1,378,466
Stockholders' Equity Attributable to Noncontrolling Interest	$8,215	$6,973	$7,762	$7,790
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$1,466,669	$1,578,118	$1,526,324	$1,386,256
Common Stock, Shares Authorized	300,000,000	300,000,000	300,000,000	300,000,000
Common Stock, Shares, Issued	132,634,850	134,602,317	135,450,364	136,305,075
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	124,060	124,060	124,060	124,060
Treasury Stock, Common, Shares	3,935,035	2,935,035	2,935,035	2,935,035

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-674,780	$94,780	$-66,038	$-223,379
Net Cash Provided by (Used in) Operating Activities	$480,666	$541,839	$601,771	$583,274
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$30,860	$32,615	$-3,611	$-25,341
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$77,132	$109,747	$106,136	$100,450
Depreciation, Depletion and Amortization	$382,783	$365,334	$381,927	$421,988
Payments to Acquire Property, Plant, and Equipment	$337,463	$306,055	$382,388	$485,594
Goodwill, Impairment Loss	$830,787	$13,078	$127,995	$272,231
Payments to Acquire Businesses, Net of Cash Acquired	$19,687	$9,536	$42,378	$151,239
Share-based Payment Arrangement, Noncash Expense	$22,468	$14,880	$21,876	$22,538
Proceeds from Divestiture of Businesses, Net of Cash Divested	—	—	$120,420	$11,015
Fair Value Adjustment of Warrants	$-34,482	$-4,021	$0	$0
Proceeds from Sale of Productive Assets	—	$5,316	$0	$1,439
Operating Lease, Right-of-Use Asset, Amortization Expense	$31,873	$32,848	$31,114	$37,113
Payments to Acquire Marketable Securities	$128	$0	$0	$0
Finance Lease, Right-of-Use Asset, Amortization	$5,938	$11,100	$15,342	$18,327
Deferred Income Tax Expense (Benefit)	$-62,595	$32,049	$47,163	$13,373
Net Cash Provided by (Used in) Investing Activities	$-357,278	$-310,275	$-303,190	$-624,379
Unrealized Gain (Loss) on Derivatives	$1,801	$367	$0	$0
Amortization of Debt Issuance Costs	$5,234	$5,666	$5,694	$4,915
Gain (Loss) on Extinguishment of Debt	$0	$-2,273	$0	$-1,322
Gain (Loss) on Disposition of Business	—	—	$32,602	$6,646
Other Noncash Income (Expense)	$-350	$-2,128	$-2,721	$-2,721
Repayments of Long-term Debt	$95,000	$423,477	$250,000	$500,000
Proceeds from Lines of Credit	$50,000	—	$0	$575,000
Finance Lease, Principal Payments	$6,769	$9,865	$18,478	$18,250
Payments for Repurchase of Common Stock	$29,275	$0	$0	$0
Proceeds from Stock Options Exercised	$587	$742	$0	$0
Proceeds from Repayment of Loans by Employee Stock Ownership Plans	$2,031	$999	$1,211	$1,598
Payments of Financing Costs	$0	$6,429	$0	$5,038
Payments to Noncontrolling Interests	$2,500	$5,600	$6,967	$6,743
Payment, Tax Withholding, Share-based Payment Arrangement	$5,843	$2,066	$2,701	$3,712
Net Cash Provided by (Used in) Financing Activities	$-92,528	$-198,949	$-302,192	$15,764
Interest Paid, Excluding Capitalized Interest, Operating Activities	$126,228	$122,072	$101,243	$97,836
Income Taxes Paid, Net	$14,756	$14,139	$24,283	$-9,312
Capital Expenditures Incurred but Not yet Paid	$35,867	$56,123	$65,892	$88,389
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$22,000	$35,871	$37,872	$62,641
Supplemental Deferred Purchase Price	$137	$0	$355	$355
Increase (Decrease) in Accounts Receivable	$28,862	$26,217	$-30,986	$-2,627
Increase (Decrease) in Inventories	$-15,531	$28,065	$11,491	$-10,288
Increase (Decrease) in Prepaid Expense and Other Assets	$20,305	$-27,325	$61,071	$46,448
IncreaseDecreaseInOperatingLeaseLiability	$-32,428	$-32,934	$-31,117	$-35,656
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$40,955	$33,832	$139,272	$87,569

Jive Data

Google Sheets add-onSheets Account

Import this data to Google Sheets with:

=jivedata("AHCO","financials")

Full statements spill as a table. For one cell: =jivedata("AHCO","Revenue") or =jivedata("AHCO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

AdaptHealth Corp.

AHCO • CIK 0001725255

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$3,200,177	$3,260,975	$3,244,857	$3,086,783
Gain (Loss) on Disposition of Business	—	—	$32,602	$6,646
Operating Income (Loss)	$-598,401	$263,732	$90,873	$-154,772
Interest Income (Expense), Nonoperating, Net	—	$-126,668	$-105,753	$-101,624
Gain (Loss) on Extinguishment of Debt	$0	$-2,273	$0	$-1,322
Fair Value Adjustment of Warrants	$-34,482	$-4,021	$0	$0
Other Nonoperating Income (Expense)	$-29,566	$-2,793	$-274	$-274
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-723,784	$136,019	$-15,154	$-257,992
Income Tax Expense (Benefit)	$-49,004	$41,239	$50,884	$-14,249
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-674,780	$94,780	$-66,038	$-223,379
Net Income (Loss) Attributable to Noncontrolling Interest	$4,115	$4,358	$4,756	$4,851
Net Income (Loss) Attributable to Parent	$-678,895	$90,422	$-70,794	$-228,230
Weighted Average Number of Shares Outstanding, Basic	134,156,000	133,756,000	135,146,000	136,199,000
Weighted Average Number of Shares Outstanding, Diluted	134,418,000	135,531,000	135,146,000	133,915,000
Cost of Goods and Services Sold	$2,720,613	$2,579,882	$2,635,658	$2,552,842
General and Administrative Expense	$190,091	$359,238	$382,293	$387,980
Goodwill, Impairment Loss	$830,787	$13,078	$127,995	$272,231
Costs and Expenses	$3,798,578	$2,997,243	$3,186,586	$3,248,201
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic	$0	$7,675	$0	$-629
Net Income (Loss) Available to Common Stockholders, Basic	$-678,895	$82,747	$-70,794	$-79,627
Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities	—	—	$0	$0
Net Income (Loss) Available to Common Stockholders, Diluted	$-713,377	$82,747	$-70,794	$-79,627
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants	262,000	0	0	0
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	0	251,000	0	0
Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends	0	1,524,000	0	0

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$77,132	$109,747	$106,136	$47,964
Accounts Receivable, after Allowance for Credit Loss, Current	$388,910	$408,019	$370,897	$390,389
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	$495,101	$474,556	$509,956	$656,368
Inventory, Net	$113,642	$139,842	$151,247	$105,480
Operating Lease, Right-of-Use Asset	$110,465	$105,999	$111,968	$127,204
Prepaid Expense and Other Assets, Current	$69,338	$45,432	$100,619	$90,219
Disposal Group, Including Discontinued Operation, Assets, Current	—	$52,748	$0	$168,098
Goodwill	$2,724,958	$2,675,166	$2,541,428	$2,370,431
Assets, Current	$649,022	$755,788	$728,899	$797,475
Intangible Assets, Net (Excluding Goodwill)	$130,160	$105,548	$85,121	$31,780
Deferred Income Tax Assets, Net	$345,854	$314,505	$267,786	$290,720
Other Assets, Noncurrent	$21,128	$17,584	$19,119	$22,090
Assets	$4,508,650	$4,486,947	$4,316,577	$4,340,869
Long-term Debt, Excluding Current Maturities	$2,094,614	$1,964,921	$1,715,983	$1,879,809
Operating Lease, Liability, Noncurrent	$85,529	$80,275	$85,470	$96,352
Finance Lease, Liability, Noncurrent	$22,746	$24,630	$32,604	$32,604
Other Liabilities, Noncurrent	$302,093	$272,016	$243,804	$243,805
Liabilities	$3,041,981	$2,908,829	$2,790,253	$2,954,613
Accounts Payable and Accrued Liabilities, Current	$391,994	$437,985	$553,700	$576,300
Long-term Debt, Current Maturities	$53,368	$16,250	$20,313	$8,125
Operating Lease, Liability, Current	$29,270	$29,945	$30,728	$36,030
Finance Lease, Liability, Current	$9,122	$14,315	$17,702	$19,337
Contract with Customer, Liability, Current	$38,570	$34,944	$59,843	$64,743
Other Liabilities, Current	$10,654	$26,505	$30,106	$4,117
Disposal Group, Including Discontinued Operation, Liabilities, Current	—	$7,043	$0	$560
Liabilities, Current	$536,999	$566,987	$712,392	$709,212
Common Stock, Value, Issued	$13	$13	$13	$14
Preferred Stock, Value, Issued	$1	$1	$1	$1
Treasury Stock, Common, Value	$43,267	$25,548	$25,548	$25,548
Additional Paid in Capital	$2,149,951	$2,156,604	$2,176,990	$2,186,940
Retained Earnings (Accumulated Deficit)	$-652,600	$-562,178	$-632,972	$-782,941
Accumulated Other Comprehensive Income (Loss), Net of Tax	$4,356	$2,253	$78	$0
Stockholders' Equity Attributable to Parent	$1,458,454	$1,571,145	$1,518,562	$1,378,466
Stockholders' Equity Attributable to Noncontrolling Interest	$8,215	$6,973	$7,762	$7,790
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$1,466,669	$1,578,118	$1,526,324	$1,386,256
Common Stock, Shares Authorized	300,000,000	300,000,000	300,000,000	300,000,000
Common Stock, Shares, Issued	132,634,850	134,602,317	135,450,364	136,305,075
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	124,060	124,060	124,060	124,060
Treasury Stock, Common, Shares	3,935,035	2,935,035	2,935,035	2,935,035

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-674,780	$94,780	$-66,038	$-223,379
Net Cash Provided by (Used in) Operating Activities	$480,666	$541,839	$601,771	$583,274
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$30,860	$32,615	$-3,611	$-25,341
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$77,132	$109,747	$106,136	$100,450
Depreciation, Depletion and Amortization	$382,783	$365,334	$381,927	$421,988
Payments to Acquire Property, Plant, and Equipment	$337,463	$306,055	$382,388	$485,594
Goodwill, Impairment Loss	$830,787	$13,078	$127,995	$272,231
Payments to Acquire Businesses, Net of Cash Acquired	$19,687	$9,536	$42,378	$151,239
Share-based Payment Arrangement, Noncash Expense	$22,468	$14,880	$21,876	$22,538
Proceeds from Divestiture of Businesses, Net of Cash Divested	—	—	$120,420	$11,015
Fair Value Adjustment of Warrants	$-34,482	$-4,021	$0	$0
Proceeds from Sale of Productive Assets	—	$5,316	$0	$1,439
Operating Lease, Right-of-Use Asset, Amortization Expense	$31,873	$32,848	$31,114	$37,113
Payments to Acquire Marketable Securities	$128	$0	$0	$0
Finance Lease, Right-of-Use Asset, Amortization	$5,938	$11,100	$15,342	$18,327
Deferred Income Tax Expense (Benefit)	$-62,595	$32,049	$47,163	$13,373
Net Cash Provided by (Used in) Investing Activities	$-357,278	$-310,275	$-303,190	$-624,379
Unrealized Gain (Loss) on Derivatives	$1,801	$367	$0	$0
Amortization of Debt Issuance Costs	$5,234	$5,666	$5,694	$4,915
Gain (Loss) on Extinguishment of Debt	$0	$-2,273	$0	$-1,322
Gain (Loss) on Disposition of Business	—	—	$32,602	$6,646
Other Noncash Income (Expense)	$-350	$-2,128	$-2,721	$-2,721
Repayments of Long-term Debt	$95,000	$423,477	$250,000	$500,000
Proceeds from Lines of Credit	$50,000	—	$0	$575,000
Finance Lease, Principal Payments	$6,769	$9,865	$18,478	$18,250
Payments for Repurchase of Common Stock	$29,275	$0	$0	$0
Proceeds from Stock Options Exercised	$587	$742	$0	$0
Proceeds from Repayment of Loans by Employee Stock Ownership Plans	$2,031	$999	$1,211	$1,598
Payments of Financing Costs	$0	$6,429	$0	$5,038
Payments to Noncontrolling Interests	$2,500	$5,600	$6,967	$6,743
Payment, Tax Withholding, Share-based Payment Arrangement	$5,843	$2,066	$2,701	$3,712
Net Cash Provided by (Used in) Financing Activities	$-92,528	$-198,949	$-302,192	$15,764
Interest Paid, Excluding Capitalized Interest, Operating Activities	$126,228	$122,072	$101,243	$97,836
Income Taxes Paid, Net	$14,756	$14,139	$24,283	$-9,312
Capital Expenditures Incurred but Not yet Paid	$35,867	$56,123	$65,892	$88,389
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$22,000	$35,871	$37,872	$62,641
Supplemental Deferred Purchase Price	$137	$0	$355	$355
Increase (Decrease) in Accounts Receivable	$28,862	$26,217	$-30,986	$-2,627
Increase (Decrease) in Inventories	$-15,531	$28,065	$11,491	$-10,288
Increase (Decrease) in Prepaid Expense and Other Assets	$20,305	$-27,325	$61,071	$46,448
IncreaseDecreaseInOperatingLeaseLiability	$-32,428	$-32,934	$-31,117	$-35,656
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$40,955	$33,832	$139,272	$87,569

AdaptHealth Corp.

Consolidated Statementsof Operations

Consolidated Balance Sheets

Consolidated Statementsof Cash Flows

AdaptHealth Corp.

Consolidated Statementsof Operations

Consolidated Balance Sheets

Consolidated Statementsof Cash Flows